Abstract
Myelomeningocele (MMC) and congenital heart disease (CHD) are independent risk factors for increased morbidity and mortality in the newborn period and each can require significant operations shortly after birth. Few studies have examined the impact of these combined lesions. We sought to examine the incidence of CHD in patients with MMC, and to evaluate length of stay (LOS), hospital charges, and mortality. Using the Texas Inpatient Public Use Data File, ~ 6.9 million newborn records between 1/1999 and 12/2016 were examined. Hospitalizations were classified as MMC without CHD (n = 3054), CHD without MMC (n = 72,266), and MMC with CHD (n = 171). The birth prevalence of CHD with MMC was 0.3/10,000 live hospital births, with 5% of patients with MMC having CHD, and 0.2% of those with CHD having MMC. There was increased LOS in patients with both MMC and CHD (median 15 days, IQR 5–31), compared to CHD without MMC (median 6 days, IQR 2–20) and MMC without CHD (median 8 days, IQR 1–14) and higher total hospital charges (median $95,007, IQR $26,731–$222,660) compared to CHD without MMC (median $27,726, $6463–$118,370) and MMC without CHD (median $40,066, IQR $5744–$97,490). Mortality was significantly higher in patients with MMC and CHD (22.2% compared to 3.1% in MMC without CHD and 4.1% in CHD without MMC). Significance remained when limiting for patients without genetic conditions or additional major birth defects. MMC with CHD in the newborn compared to either CHD or MMC alone is associated with longer LOS, higher charges, and increased mortality.
Similar content being viewed by others
Data Availability
The Texas inpatient public use data file is available by request from the Texas Department of State Health Services.
Code Availability
International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) or Tenth Revision, Clinical Modification (ICD-10) codes.
References
Parker SE, Mai CT, Canfield MA et al (2010) Updated national birth prevalence estimates for selected birth defects in the United States, 2004–2006. Birth Defects Res Part A Clin Mol Teratol 88:1008–1016. https://doi.org/10.1002/bdra.20735
Blom HJ, Smulders Y (2011) Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. J Inherit Metab Dis 34:75–81. https://doi.org/10.1007/s10545-010-9177-4
Williams J, Mai CT, Mulinare J (2015) National birth defects prevention month and folic acid awareness week—January 2015 updated estimates of neural tube defects prevented by mandatory folic acid fortification—United States, 1995–2011. Centers Dis Control Prev Morb Mortal Wkly Rep 64:1–6
Canfield MA, Honein MA, Yuskiv N et al (2006) National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999–2001. Birth Defects Res Part A Clin Mol Teratol 76:747–756. https://doi.org/10.1002/bdra.20294
Liu S, Joseph KS, Luo W et al (2016) Effect of folic acid food fortification in Canada on congenital heart disease subtypes. Circulation 134:647–655. https://doi.org/10.1161/CIRCULATIONAHA.116.022126
Abouk R, Grosse SD, Ailes EC, Oster ME (2017) Association of US State implementation of newborn screening policies for critical congenital heart disease with early infant cardiac deaths. JAMA 318:2111. https://doi.org/10.1001/jama.2017.17627
Shin M, Kucik JE, Siffel C et al (2012) Improved survival among children with spina bifida in the United States. J Pediatr 161:1132-1137.e3. https://doi.org/10.1016/j.jpeds.2012.05.040
Adzick NS, Thom EA, Spong CY et al (2011) A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 364:993–1004. https://doi.org/10.1056/NEJMoa1014379
Moon-Grady AJ, Morris SA, Belfort M et al (2015) International fetal cardiac intervention registry: a worldwide collaborative description and preliminary outcomes. J Am Coll Cardiol 66:388–399. https://doi.org/10.1016/j.jacc.2015.05.037
Deptartment of State Health (2019) Texas inpatient public use data file. https://www.dshs.texas.gov/thcic/hospitals/Inpatientpudf.shtm. Accessed 7 Jan 2019
Yoon PW, Rasmussen SA, Lynberg MC et al (2001) The national birth defects prevention study. Public Health Rep 116:32–40. https://doi.org/10.1093/phr/116.s1.32
U.S B of L and S (2019) Consumer Price Index inflation calculator. https://data.bls.gov/cgi-bin/cpicalc.pl. Accessed 17 Feb 2019
American Institute of Ultrasound in Medicine (2013) Practice parameter for the performance of fetal echocrdiography
Vernon MM, Powell D, Schultz AH et al (2015) Is routine preoperative transthoracic echocardiography necessary in newborns with myelomeningocele? J Perinatol 35:842–845. https://doi.org/10.1038/jp.2015.74
Ritter S, Tani LY, Shaddy RE, Minich LL (1999) Are screening echocardiograms warranted for neonates with meningomyelocele? Arch Pediatr Adolesc Med 153:1264–1266
Moeini Naghani I, Hashemi Zonouz T, Shahjouei S et al (2014) Congenital cardiac anomalies in myelomeningocele patients. Acta Med Acad 43:160–164. https://doi.org/10.5644/ama2006-124.115
Koçak G, Onal C, Koçak A et al (2008) Prevalence and outcome of congenital heart disease in patients with neural tube defect. J Child Neurol 23:526–530. https://doi.org/10.1177/0883073807309789
Funding
No specific support.
Author information
Authors and Affiliations
Contributions
JKW and SAM conceptualized and designed the study, carried out data analysis, drafted the initial manuscript, and reviewed and revised the manuscript. WEW critically reviewed and revised the manuscript for important intellectual content. YW assisted in data analysis. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest relevant to this article to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wilkes, J.K., Whitehead, W.E., Wang, Y. et al. Congenital Heart Disease and Myelomeningocele in the Newborn: Prevalence and Mortality. Pediatr Cardiol 42, 1026–1032 (2021). https://doi.org/10.1007/s00246-021-02576-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-021-02576-3